## **Core Concept**
In long protocol IVF (In Vitro Fertilization), GnRH (Gonadotropin-Releasing Hormone) agonists are used to prevent premature ovulation by downregulating the pituitary gland. This allows for better control over follicular development and egg maturation.

## **Why the Correct Answer is Right**
The correct answer involves starting the GnRH agonist in the luteal phase of the preceding menstrual cycle, which is typically around day 21 of a 28-day menstrual cycle. This timing allows for pituitary downregulation to occur before the initiation of ovarian stimulation, reducing the risk of premature luteinization and ovulation. The downregulation period usually lasts for 10-14 days, after which ovarian stimulation with gonadotropins begins.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Starting GnRH agonist on day 1 of the menstrual cycle would not allow sufficient time for downregulation to occur before starting ovarian stimulation, potentially leading to premature ovulation.
- **Option B:** Initiating GnRH agonist on day 2 or 3 might not provide enough time for effective downregulation and could interfere with the early stages of follicular development.
- **Option D:** Starting GnRH agonist on the day of ovarian stimulation (or later) would not provide the necessary downregulation to prevent premature ovulation effectively.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the long protocol of IVF involves starting GnRH agonists in the mid-luteal phase (around day 21) of the cycle preceding IVF, allowing for effective pituitary downregulation. This approach significantly improves the chances of successful IVF by preventing premature ovulation.

## **Correct Answer:** . On day 21 of the preceding menstrual cycle.